| Recruiting | A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis Adolescents With Moderate-to-severe Atopic Dermatitis | Phase 3 | 2026-03-21 |
| Not Yet Recruiting | A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum Pyoderma Gangrenosum | Phase 2 | 2026-03-05 |
| Not Yet Recruiting | A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | A Study of SHR-2173 in Participants With Primary IgA Nephropathy Primary IgA Nephropathy | Phase 2 | 2026-02-01 |
| Recruiting | A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis Moderate to Severe Active Rheumatoid Arthritis | Phase 2 | 2026-01-19 |
| Recruiting | A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis | Phase 2 | 2026-01-09 |
| Recruiting | Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, Primary Membranous Nephropathy | Phase 2 | 2025-12-31 |
| Not Yet Recruiting | A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Dev Atopic Dermatitis | Phase 1 | 2025-12-01 |
| Recruiting | A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to Adult Patients With Moderately to Severely Active Ulcerative Colitis | Phase 2 | 2025-12-01 |
| Recruiting | A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With A Active Lupus Nephritis | Phase 2 | 2025-11-22 |
| Recruiting | Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia Immune Thrombocytopenia | Phase 1 | 2025-11-12 |
| Recruiting | A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatit Moderate-to-severe Atopic Dermatitis | Phase 2 | 2025-11-07 |
| Not Yet Recruiting | Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects Pulmonary Fibrosis | Phase 1 | 2025-11-01 |
| Recruiting | Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety o IPF and PPF | Phase 2 | 2025-10-29 |
| Recruiting | The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects Rheumatoid Arthritis (RA) | Phase 1 | 2025-10-08 |
| Recruiting | A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma Asthma | Phase 3 | 2025-09-03 |
| Recruiting | Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2025-08-28 |
| Recruiting | A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9 COPD | Phase 1 | 2025-08-11 |
| Recruiting | A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patie Seasonal Allergic Rhinitis | Phase 2 | 2025-08-06 |
| Active Not Recruiting | A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2025-06-09 |
| Completed | A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects Pulmonary Fibrosis | Phase 1 | 2025-05-04 |
| Active Not Recruiting | A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 Rheumatoid Arthritis | Phase 1 | 2025-04-08 |
| Not Yet Recruiting | Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma Asthma | Phase 2 | 2025-04-01 |
| Active Not Recruiting | A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis | Phase 2 | 2025-03-28 |
| Recruiting | A Trial of HRS-9813 in Healthy Subjects Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis | Phase 1 | 2025-02-17 |
| Completed | Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthma | Phase 2 | 2025-01-23 |
| Recruiting | A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Children and Adolescents With Moderate-to-severe Atopic Dermatitis | Phase 1 / Phase 2 | 2024-12-18 |
| Completed | A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multi Systemic Lupus Erythematosus | Phase 1 | 2024-11-24 |
| Recruiting | A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1 Asthma With Eosinophilic Phenotype | Phase 3 | 2024-11-21 |
| Recruiting | Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis Prurigo Nodularis | Phase 2 / Phase 3 | 2024-09-19 |
| Completed | A Trial of HRS-9813 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2024-07-24 |
| Recruiting | A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Pat Eosinophilic Asthma Patients | Phase 2 | 2024-07-19 |
| Completed | A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Hea Moderate to Severe Plaque Psoriasis | Phase 1 | 2024-06-26 |
| Active Not Recruiting | Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis Moderate to Severe Atopic Dermatitis | Phase 3 | 2024-06-14 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects, Asthmatic Patients | Phase 1 | 2024-05-07 |
| Completed | Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Inje Healthy Volunteers | Phase 1 | 2024-04-28 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Sub Prevention of Graft Rejection After Organ Transplantation | Phase 1 | 2023-11-29 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Poly Eosinophilic Granulomatosis With Polyangiitis | Phase 2 / Phase 3 | 2023-11-16 |
| Active Not Recruiting | Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2023-09-04 |
| Completed | A Phase I Study of SHR -2001 in Healthy Subjects Healthy | Phase 1 | 2023-07-19 |
| Unknown | Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects Kidney Transplantation | Phase 1 | 2023-07-11 |
| Terminated | Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy Primary IgA Nephropathy | Phase 2 | 2023-06-04 |
| Completed | Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 2 | 2023-03-29 |
| Completed | A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough Refractory Chronic Cough | Phase 2 | 2023-03-09 |
| Completed | Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects Chronic Obstructive Pulmonary Disease | Phase 1 | 2023-01-12 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenousl IgA Nephropathy | Phase 1 | 2022-06-30 |
| Completed | A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration Chronic Cough | Phase 1 | 2022-03-28 |
| Completed | A Trial of SHR - 1906 in Healthy Subjects Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-08-10 |